European Journal of Haematology
Publisher: Wiley · ISSN 09024441 · 74 articles
- Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants
- Issue Information
- Engineering Hematopoietic Immunity: The Next Evolution of Transplantation and Cellular Therapy
- Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory mIDH1 AML
- Trends in Global Anemia Prevalence Among Women of Reproductive Age, 2000–2023
- Navigating the Paradigm Shift in Chronic Lymphocytic Leukemia: Insights From EHA 2026
-
Measurable Residual Disease in IDH‐Mutated AML: Identifying a Clinically Relevant Threshold for IDH Mutation Monitoring
ABSTRACT Background Isocitrate dehydrogenase ( IDH ) mutations are recurrent in acute myeloid leukemia (AML) and represent promising targets for measurable residual disease (MRD) monitoring. However, clinically validated strategies for...
-
Long‐Term Durability and Safety Signals of Systemic AAV Gene Therapy for Haemophilia A and B: A Systematic Review
ABSTRACT Background Adeno‐associated virus (AAV) gene therapy can provide sustained endogenous factor expression after a single infusion, but durability and safety differ across products. We synthesised long‐term efficacy and clinically...
-
T‐Cell Response After SARS‐CoV‐2 Vaccination in Patients With Hematological Malignancy
ABSTRACT Patients with hematologic malignancies (HM) often mount poor humoral responses to SARS‐CoV‐2 vaccination due to their immunocompromised status. Protection against severe COVID‐19 is strongly related to cellular immunity, yet...
-
Older Age and Complex Karyotype Are the Main Predictors of Mortality Irrespective of Transplantation in Therapy‐Related Myeloid Neoplasms
ABSTRACT Therapy‐related myeloid neoplasms (t‐MN) are late complications of cancer therapies. We retrospectively analyzed 86 adults diagnosed from 2007 to 2025 with t‐MN (acute myeloid leukemia [AML] n = 31, myelodysplastic neoplasms...
-
HCT‐FS‐Defined Frailty Is Associated With Lower Survival Across Diverse Hematologic Diagnoses After Allogeneic Transplantation
ABSTRACT Objectives To evaluate whether Hematopoietic Cell Transplantation Frailty Scale (HCT‐FS)‐defined frailty predicts overall survival (OS), nonrelapse mortality (NRM), and relapse across diverse hematologic diagnoses undergoing...
-
Efficacy and Safety of Doxorubicin–Etoposide–Methylprednisolone (DEP)‐Based Regimens in Haemophagocytic Lymphohistiocytosis: A Systematic Review and Meta‐Analysis
ABSTRACT Background Haemophagocytic lymphohistiocytosis (HLH) is a rare but severe hyperinflammatory syndrome caused by uncontrolled immune activation. Etoposide‐containing regimens are established in paediatric HLH, but evidence in...
-
Hepatitis‐Associated Aplastic Anemia in Children and Adolescents: A Comprehensive Review
ABSTRACT Hepatitis‐associated aplastic anemia (HAAA) is a rare but life‐threatening subtype of acquired aplastic anemia (AA) that predominantly affects children and adolescents, characterized by bone marrow failure developing weeks to...
-
Partial Red Cell Exchange in the Secondary Prevention of Stroke in Sickle Cell Disease: A Prospective Study
ABSTRACT Introduction Stroke is a severe complication associated with sickle cell disease (SCD). The risk of recurrence is extremely high. The present study aimed to assess the clinical and biological efficacy of Partial Red Cell...
-
Chimeric Antigen Receptor T‐Cell Therapy in T Cell/Histiocyte‐Rich Large B‐Cell Lymphoma: A Systematic Review and Meta‐Analysis
ABSTRACT T‐cell/histiocyte‐rich large B‐cell lymphoma (THRLBCL) is a rare subtype of B‐cell non‐Hodgkin lymphoma with an aggressive clinical course and poor prognosis in the case of relapsed or refractory ( r / r ) disease. Recently,...
-
Association Between the Time of Day of Post‐Transplant Cyclophosphamide Administration and Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation
ABSTRACT Objective To evaluate the impact of the time‐of‐day (daytime vs. nighttime) of the infusion of post‐transplantation cyclophosphamide (PTCy) on the occurrence of haemorrhagic cystitis (HC) in adult patients undergoing allogeneic...
-
Elevated Risks for Depression and Anxiety Following Diagnosis of Multiple Myeloma
ABSTRACT Background Patients with multiple myeloma (MM) may be particularly vulnerable to depression and anxiety following diagnosis due to high disease burden, treatment‐related side effects, and the incurable nature of the disease....
- Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia
- From Platelet‐Transfusion Risk to the Decision That Matters in Thrombotic Thrombocytopenic Purpura
-
BCMA‐Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management
ABSTRACT Background B‐cell maturation antigen (BCMA), a plasma cell‐restricted member of the tumor necrosis factor receptor superfamily, has emerged as the premier immunotherapeutic target in Multiple Myeloma (MM). Methods We performed...
- Composite Complication Endpoints May Obscure Bleeding Risk in Pediatric Central Venous Catheterization
- HMOX1‐Associated Neutrophil Engraftment in Pediatric HSCT Requires Evidence Beyond an Early Time Window
-
Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B‐Cell Lymphoma
ABSTRACT Background Extranodal (EN) involvement is common in diffuse large B‐cell lymphoma (DLBCL), but current prognostic models inadequately capture the anatomical complexity of EN dissemination. We evaluated primary multifocal...
-
Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly...
- Steroid Response Prediction in Children With Diamond–Blackfan Anemia Requires Age at Treatment, Not Diagnosis
-
BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort
ABSTRACT Objectives B‐cell maturation antigen (BCMA)‐targeted therapies have recently transformed the management of relapsed or refractory multiple myeloma (RRMM). This study aimed to evaluate their implementation and real‐world impact...
- Comment on Sakthivel Et al., “Central Venous Access Device Complications in Children With Leukemia: A Systematic Review and Meta‐Analysis”
-
Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives
ABSTRACT Castleman disease (CD) comprises a heterogenous group of rare nonmalignant lymphoproliferative disorders. CD is classified as unicentric (UCD) and multicentric CD (MCD) depending on the number of lymph node region involvement....
-
Posaconazole Prophylaxis for the Prevention of Invasive Fungal Infections in Patients With Hematologic Malignancies: A Systematic Review and Meta‐Analysis
ABSTRACT Background Invasive fungal infections (IFIs) pose a life‐threatening risk to patients with hematologic malignancies undergoing intensive chemotherapy. Although posaconazole is widely used as a standard prophylactic agent, a...
-
Ferritin Normalization Is Not Disease Control in HFE‐Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin–Ferroportin Axis
ABSTRACT HFE ‐related hemochromatosis is conventionally managed as a disorder of iron excess, with therapeutic phlebotomy as effective, inexpensive, first‐line therapy. Ferritin normalization, however, may not fully capture clinical...